SCIT with a high-dose house dust mite allergoid is well tolerated: safety data from pooled clinical trials and more than 10 years of daily practice analyzed in different subgroups-Reference-Cited by-同舟云学术

SCIT with a high-dose house dust mite allergoid is well tolerated: safety data from pooled clinical trials and more than 10 years of daily practice analyzed in different subgroups

Published:2018-07-25 Issue:5 Volume:27 Page:131-139
ISSN:2197-0378
Container-title:Allergo Journal International
language:en
Short-container-title:Allergo J Int

Author:

Klimek Ludger,Fox Gabriele-Cornelia,Thum-Oltmer Susanne

Publisher

Springer Science and Business Media LLC

Subject

Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s40629-018-0059-x.pdf

Reference16 articles.

1. Pfaar O, Bachert C, Bufe A, Buhl R, Ebner C, Eng P, et al. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (OGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD). Allergo J Int. 2014;23:282–319.

2. Roberts G, Pfaar O, Akdis CA, Ansotegui IJ, Durham SR, Gerth van Wijk R, et al. EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy. 2017; https://doi.org/10.1111/all.13317 .

3. Calderon MA, Kleine-Tebbe J, Linneberg A, De Blay F, Hernandez Fernandez de Rojas D, Virchow JC, et al. House dust mite respiratory allergy: an overview of current therapeutic strategies. J Allergy Clin Immunol Pract. 2015;3:843–55.

4. Global strategy for asthma management and prevention. https://www.ginasthma.org . 2017. Accessed 02/01/2018

5. Dhami S, Nurmatov U, Agache I, Lau S, Muraro A, Jutel M, et al. Allergen immunotherapy for allergic asthma: protocol for a systematic review. Clin Transl Allergy. 2015;6:5.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evidence for commercial house dust mite immunotherapy products: A pragmatic systematic review with narrative synthesis;Journal of Allergy and Clinical Immunology: Global;2024-08

2. The pharmacotherapeutic management of allergic rhinitis in people with asthma;Expert Opinion on Pharmacotherapy;2024-01-02

3. Safety of subcutaneous and sublingual immunotherapy with allergoids in children: a real-life pharmacovigilance study;Immunotherapy;2024-01

4. A novel dose-adjustment protocol for interrupted subcutaneous immunotherapy for allergic rhinitis;Immunotherapy;2023-10

5. New approaches to immunotherapy in house dust mite allergy;Clinical and Experimental Pediatrics;2023-04-15